Brightview Medical's Self-Developed 'StellarScope®' Installed in Three Top U.S. Institutions, Setting a New Benchmark for Chinese High-End Ophthalmic Equipment Going Global

-01-

This is a vote of confidence in technology.

Robotrak TechnologiesStellarVision® Adaptive Optics Retinal Imaging System(hereinafter referred to as"StarLens®"), is completing a leap from technological breakthrough to recognition within the international scientific research system.

It is worth noting that,These three institutions belong to three distinct fields—ophthalmic clinical research, neuropsychiatric cross-disciplinary research, and optometric scientific research and education—yet they all chose equipment from the same Chinese company. This inevitably raises the question: In a landscape where high-end medical devices have long been monopolized by international giants, what has earned such professional trust for products made in China?

-02-

Not Just "Seeing the Eye Clearly," but Opening a Window to Observe Overall Health

Adaptive optics technology has been rated as one of the most influential technologies in the field of ophthalmic imaging in the 21st century. However, due to challenges such as bulky equipment, complex operation, poor stability, and research and development costs as high as tens of millions of US dollars, it has long been difficult to move from the laboratory to clinical settings, seriously hindering its commercialization and clinical popularization.

The innovation of Robotrak Technologies lies in,This technology has been successfully miniaturized, integrated, and commercialized, with the lateral resolution of fundus imaging improved to 0.7 micrometers, achieving sub-micron level cellular imaging of the living human retina.

Traditional fundus examination can visualize blood vessels and the optic disc, whileStellarLens®Allow doctors and researchers to directly visualize the morphology and distribution of microscopic structures such as photoreceptor cells and immune cells.This shift in perspective from "macro" to "micro" means that the timing of disease diagnosis and research could be significantly advanced, with more refined evaluation dimensions.

More crucially,The retina is the only tissue in the human body that can be observed non-invasively and directly, where blood vessels and nerves are visible, and it is called"Window to the Brain"Therefore, the value of ultra-high-resolution fundus imaging technology extends far beyond ophthalmology itself. This also explains whyWestern Psychiatric Institute of the University of Pittsburgh Medical CenterAs a top psychiatry research institute, it will introduce this device.

What they are interested in, it is precisely by observing the morphological changes of immune cells in the retina to explore the possibility of early biomarkers for neurological diseases. This interdisciplinary research perspective,This is precisely the cutting-edge direction of current precision medicine.

-03-

Entering top-tier institutions means entering the core of the global innovation cycle.

For high-end scientific research equipment, entering top research institutions is of extraordinary significance. These institutions are not only "users" of the equipment but also one of the "definers" of future research methods, clinical pathways, and even industry standards.

InUPMC Eye Center, University of Pittsburgh, despite having its own self-built adaptive optics scanning laser ophthalmoscope (AO-SLO) laboratory system, butDue toAO-SLO PrototypeComplex device operation,Low imaging efficiency and high patient cooperation requirements lead to unstable imaging success rates, making it difficult to support large-scale clinical research.This has seriously restricted the exploration of the deep mechanisms of major eye diseases such as age-related macular degeneration (AMD) and diabetic retinopathy, as well as the advancement of cutting-edge research on functional connectivity in the retina-brain neural pathways.

AndStellarVision® has completely transformed this situation — its highly integrated and automated design significantly enhances operational efficiency and imaging stability.According to the feedback from the research institute, researchers often failed to obtain valid images when they operated their own AO-SLO systems independently in the past.After using StarMirror®, even researchers who are handling it for the first time can quickly...、Stably obtain high-quality cellular-level retinal images.This not only significantly enhances the feasibility of clinical research but also enables large-scale cohort studies.ForPossibly, its research achievements are expected to directly reshape the global guidelines for the diagnosis and treatment of related diseases.

InState University of New York College of OptometryAs one of the top optometric education and clinical research centers in the U.S., the college has also equipped itself with a self-developed AO-SLO system for visual physiology and visual function research. However, limited by the inefficiency and instability of traditional systems, the device has long been able to serve only small-scale basic experiments, making it difficult to integrate into daily teaching and large-scale clinical training.The introduction of StarLens® resolves this core bottleneck: its user-friendly, high success rate imaging capability enables students and researchers to efficiently acquire reliable data, truly incorporating cellular-level fundus imaging technology into the optometry training system.

In the future,StarLens®It will become the core clinical tool for the college to conduct vision science research and optometry talent training, not only supporting the advancement of cutting-edge topics but also ensuring that the next generation of optometrists has a solid practical foundation in mastering advanced diagnostic technologies.

Robotrak Technologies' move is equivalent to directly embedding its products into the "pipeline" of cutting-edge innovation in global ophthalmology and vision science. Genuine feedback and usage requirements from these top-tier teams will become the most valuable nutrients for product iteration. This marks a shift from selling equipment to co-building an ecosystem.

04-

The Logic Behind the Overseas Expansion of China's High-End Medical Devices is Changing

In the past, Chinese medical device exports mostly relied on cost-effectiveness, targeting mid-to-low-end markets or developing country markets.StellarLens®With globally leading core technology, directly enter the high-end scientific research market and top medical institutions that are relatively insensitive to price but extremely demanding in terms of technology.

This path is obviously more difficult.It requires enterprises not only to achieve true technological"From 0 to 1"Or"From 1 to 10"The breakthrough,We must also deeply understand global top scientific research users.And top medical institutionsThe demand, establish a professional international clinical support system, and withstand the most stringent peer review and long-term stability tests.

But the value of this path is even higher. Once a reputation and trust are established in the top-tier research market, it will create strong momentum by extending downward to the high-end clinical market and expanding outward to interdisciplinary fields. This is not just the victory of one or two orders, but also the establishment of“Technologically Advanced, Professionally Reliable”New Understanding.

For Robotrak Technologies, this is both an opportunity and a responsibility. It requires continuous investment and in-depth collaboration with research teams to jointly explore the human retina.The Unknown of HealthTerritory. And for China's high-end medical industry, Robotrak TechnologiesThe therapy provides an interesting sample to observe: when technological breakthroughs meet a globalized research ecosystem, how to navigate the path from"China Innovation"To"Global Value"The last mile.

Focus on 「Herbal Capital"】WeChat Official Account and set it as 'Starred ⭐' to get the latest updates第一时间收获最新推送"